119 related articles for article (PubMed ID: 15033668)
1. Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2.
Merimsky O; Gez E; Weitzen R; Nehushtan H; Rubinov R; Hayat H; Peretz T; Ben-Shahar M; Biran H; Katsenelson R; Mermershtein V; Loven D; Karminsky N; Neumann A; Matcejevsky D; Inbar M
Ann Oncol; 2004 Apr; 15(4):610-2. PubMed ID: 15033668
[TBL] [Abstract][Full Text] [Related]
2. Inhaled interleukin-2 therapy in pulmonary metastatic renal cell carcinoma: six years of experience.
Huland E; Heinzer H; Mir TS; Huland H
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S98-105. PubMed ID: 9457403
[TBL] [Abstract][Full Text] [Related]
3. Overview of interleukin-2 inhalation therapy.
Huland E; Heinzer H; Huland H; Yung R
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S104-12. PubMed ID: 10685669
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of pulmonary metastatic renal cell carcinoma: success dependant on risk factors?
Huland E; Heinzer H; Huland H
Hepatogastroenterology; 1999 May; 46 Suppl 1():1257-62. PubMed ID: 10429971
[TBL] [Abstract][Full Text] [Related]
5. Adoptive immunotherapy of patients with metastatic renal cell cancer using lymphokine-activated killer cells, interleukin-2 and cyclophosphamide: long-term results.
Tomita Y; Katagiri A; Saito K; Imai T; Saito T; Tanikawa T; Terunuma M; Nishiyama T; Takahashi K
Int J Urol; 1998 Jan; 5(1):16-21. PubMed ID: 9535595
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness and limitation of immunotherapy of metastatic renal cell carcinoma with autologous lymphokine-activated killer cells and interleukin 2].
Nakano E; Iwasaki A; Seguchi T; Sugao H; Tada Y; Matsuda M; Sonoda T
Nihon Hinyokika Gakkai Zasshi; 1991 Mar; 82(3):395-404. PubMed ID: 2072602
[TBL] [Abstract][Full Text] [Related]
7. Treatment of pulmonary metastatic renal-cell carcinoma in 116 patients using inhaled interleukin-2 (IL-2).
Huland E; Heinzer H; Huland H
Anticancer Res; 1999; 19(4A):2679-83. PubMed ID: 10470219
[TBL] [Abstract][Full Text] [Related]
8. Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatment.
Huland E; Heinzer H; Huland H
J Cancer Res Clin Oncol; 1994; 120(4):221-8. PubMed ID: 8288676
[TBL] [Abstract][Full Text] [Related]
9. Retrospective review in patients with pulmonary metastases of renal cell carcinoma receiving inhaled recombinant interleukin-2.
Esteban-González E; Carballido J; Navas V; Torregrosa Z; Muñoz A; de Mon MA;
Anticancer Drugs; 2007 Mar; 18(3):291-6. PubMed ID: 17264761
[TBL] [Abstract][Full Text] [Related]
10. High dose inhalation interleukin-2 therapy for lung metastases in patients with malignant melanoma.
Enk AH; Nashan D; Rübben A; Knop J
Cancer; 2000 May; 88(9):2042-6. PubMed ID: 10813715
[TBL] [Abstract][Full Text] [Related]
11. [Complete remission of pulmonary metastasis from renal cell carcinoma through inhalation therapy with Interleukin-2 after unsuccessful systemic immunochemotherapy].
Rohrmann K; Schleypen J; Adam C; Hofstetter A; Siebels M
Urologe A; 2004 Oct; 43(10):1271-4. PubMed ID: 15372156
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
[TBL] [Abstract][Full Text] [Related]
13. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.
Cangiano T; Liao J; Naitoh J; Dorey F; Figlin R; Belldegrun A
J Clin Oncol; 1999 Feb; 17(2):523-8. PubMed ID: 10080595
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial embolization with spherical embolic agent for pulmonary metastases from renal cell carcinoma.
Seki A; Hori S; Sueyoshi S; Hori A; Kono M; Murata S; Maeda M
Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1527-1535. PubMed ID: 23430025
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study on recombinant human interleukin-2 (Proleukin) in the treatment of metastatic renal cell carcinoma].
Sheng XN; Li JL; Guo J; Zhao XH; Zhu J; Chu DT
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):129-33. PubMed ID: 18646697
[TBL] [Abstract][Full Text] [Related]
16. [Regional immunotherapy of metastatic renal cell carcinoma].
Heinzer H; Huland E; Huland H
Urologe A; 2002 May; 41(3):239-48. PubMed ID: 12132273
[TBL] [Abstract][Full Text] [Related]
17. [Inhaled immunotherapy for pulmonary metastases of renal cell cancer].
Lümmen G; Schenck M; Börgermann C; Eisenhardt A; Vom Dorp F; Sperling H; Rübben H
Urologe A; 2004 Apr; 43(4):457-61. PubMed ID: 15085267
[TBL] [Abstract][Full Text] [Related]
18. Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2.
Lissoni P; Bordin V; Vaghi M; Fumagalli L; Bordoni A; Mengo S; Bucovec R; Fumagalli E; Malugani F; Ardizzoia A; Giani L; Gardani GS; Tancini G
Anticancer Res; 2002; 22(2B):1061-4. PubMed ID: 12168901
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of pulmonary metastases from kidney cell carcinoma with inhalational interleukin-2. 10-year experience Hamburger Unicenter].
Heinzer H; Huland E; Aalamian M; Huland H
Urologe A; 1999 Sep; 38(5):466-73. PubMed ID: 10501705
[TBL] [Abstract][Full Text] [Related]
20. Inhalation of interleukin-2 combined with subcutaneous administration of interferon for the treatment of pulmonary metastases from renal cell carcinoma.
Nakamoto T; Kasaoka Y; Mitani S; Usui T
Int J Urol; 1997 Jul; 4(4):343-8. PubMed ID: 9256321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
